Search - tctmd.com

Displaying 101 - 120 of 198

Sort: Relevancy | Date

News Industry News

Plaque Modification With Scoring Balloon Improves Angiographic Outcomes In Patients Treated With A Drug-Coated Balloon For Drug-Eluting Stent Restenosis

October 14, 2015

News Conference News TCT 2015

ISAR-DESIRE 4: Scoring Balloon Predilation Effective at 1 Year in Patients With DES Restenosis

October 14, 2015

News Conference News TCT 2015

IN.PACT SFA: Benefits of DCB Persist at 2 Years

October 14, 2015

News Industry News

Drug-Coated Balloon Shown To Be Superior To Conventional Angioplasty In Treating Superficial Femoral Artery Disease After Two Years

October 14, 2015

News Conference News TCT 2015

Second-Generation DES, DCB Both Strategies for Treating In-Stent Restenosis

October 12, 2015

News Industry News

QT Vascular Announces Interim Clinical Trial Results Of Chocolate Touch

October 06, 2015

News Industry News

Intact Vascular Announces Conditional FDA Approval for Tack Optimized Balloon Angioplasty II (TOBA II) Study and Enrollment of First Patients

September 30, 2015

News Industry News

Proteon Therapeutics Announces Top-Line Results From Phase 1 Study of Investigational Drug Vonapanitase in Patients With Symptomatic Peripheral Artery Disease

August 14, 2015

News Industry News

Spectranetics Completes Enrollment in ILLUMENATE Pivotal Study to Assess Safety and Efficacy of Stellarex(TM) Drug-Coated Balloon Technology

July 29, 2015

News Daily News

Registry Provides Reassurance About Rotational Atherectomy Pre-PCI

Todd Neale

July 23, 2015

News Daily News

Meta-analysis Confirms Safety of PCI without Surgical Backup

July 16, 2015

News Daily News

RIBS IV: Los SLE Superan a los BRF en el Manejo de la Reestenosis Intra-Stent

L.A. McKeown

July 01, 2015

News Daily News

RIBS IV: EES Surpass DCB for Treatment of In-Stent Restenosis

L.A. McKeown

July 01, 2015

News Daily News

RIBS IV：EES 支架内再狭窄治疗效果超越 DCB

L.A. McKeown

July 01, 2015

Presentation

Late Restenosis After Paclitaxel-Coated Balloon Angioplasty in Patients With DES Restenosis

Presenter: Seiji Habara

June 30, 2015

News Daily News

LEVANT 2: DCB Beats Standard Balloon Angioplasty at 1 Year in Femoropopliteal Disease

Yael L. Maxwell

June 26, 2015

News Industry News

The New England Journal of Medicine publishes LEVANT 2 results for the Lutonix® Drug Coated Balloon, showing superior efficacy compared to standard PTA

June 25, 2015

News Industry News

Medtronic Initiates U.S. Launch of Fortrex(TM) PTA Balloon

June 10, 2015

News Daily News

Stenting Provides Better Early Outcomes vs Angioplasty Alone for PAD

Todd Neale

June 08, 2015

News Daily News

ISAR-DESIRE 3: Drug-Coated Balloon Shows Durable Antirestenotic Effect in DES Restenosis

L.A. McKeown

June 03, 2015

Advertisement

Plaque Modification With Scoring Balloon Improves Angiographic Outcomes In Patients Treated With A Drug-Coated Balloon For Drug-Eluting Stent Restenosis

ISAR-DESIRE 4: Scoring Balloon Predilation Effective at 1 Year in Patients With DES Restenosis

IN.PACT SFA: Benefits of DCB Persist at 2 Years

Drug-Coated Balloon Shown To Be Superior To Conventional Angioplasty In Treating Superficial Femoral Artery Disease After Two Years

Second-Generation DES, DCB Both Strategies for Treating In-Stent Restenosis

QT Vascular Announces Interim Clinical Trial Results Of Chocolate Touch

Intact Vascular Announces Conditional FDA Approval for Tack Optimized Balloon Angioplasty II (TOBA II) Study and Enrollment of First Patients

Proteon Therapeutics Announces Top-Line Results From Phase 1 Study of Investigational Drug Vonapanitase in Patients With Symptomatic Peripheral Artery Disease

Spectranetics Completes Enrollment in ILLUMENATE Pivotal Study to Assess Safety and Efficacy of Stellarex(TM) Drug-Coated Balloon Technology

Registry Provides Reassurance About Rotational Atherectomy Pre-PCI

Meta-analysis Confirms Safety of PCI without Surgical Backup

RIBS IV: Los SLE Superan a los BRF en el Manejo de la Reestenosis Intra-Stent

RIBS IV: EES Surpass DCB for Treatment of In-Stent Restenosis

RIBS IV：EES 支架内再狭窄治疗效果超越 DCB

Late Restenosis After Paclitaxel-Coated Balloon Angioplasty in Patients With DES Restenosis

LEVANT 2: DCB Beats Standard Balloon Angioplasty at 1 Year in Femoropopliteal Disease

The New England Journal of Medicine publishes LEVANT 2 results for the Lutonix® Drug Coated Balloon, showing superior efficacy compared to standard PTA

Medtronic Initiates U.S. Launch of Fortrex(TM) PTA Balloon

Stenting Provides Better Early Outcomes vs Angioplasty Alone for PAD

ISAR-DESIRE 3: Drug-Coated Balloon Shows Durable Antirestenotic Effect in DES Restenosis

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content